Although the clinicopathological features of BRCA1 associated breast tumors are studied widely and previous studies showed that BRCA1 positive tumors demonstrated higher tumor grade, lower estrogen receptor expression, and lower progesterone receptor expression [55–57], the status of ER and PR expression among young and older BRCA1 associated breast cancer patients is less well studied. The gene discussed is ESR1; the disease is breast cancer.